Clearpoint Neuro, Inc. (CLPT)
12.98
-0.13
(-0.99%)
USD |
NASDAQ |
Dec 11, 16:00
13.35
+0.37
(+2.85%)
After-Hours: 20:00
Clearpoint Neuro Cash from Investing (Quarterly): -0.199M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -15.59M |
| Masimo Corp. | 282.30M |
| Perspective Therapeutics, Inc. | 13.99M |
| Xtant Medical Holdings, Inc. | 4.679M |
| VolitionRX Ltd. | 0.0012M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.121M |
| Free Cash Flow | -13.82M |
| Free Cash Flow Per Share (Quarterly) | -0.1168 |
| Free Cash Flow to Equity (Quarterly) | -3.609M |
| Free Cash Flow to Firm (Quarterly) | -2.776M |
| Free Cash Flow Yield | -3.80% |